Found: 3
Select item for more details and to access through your institution.
Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40829-2
- By:
- Publication type:
- Article
A multi‐ethnic analysis of immune‐related gene expression signatures in patients with ovarian clear cell carcinoma.
- Published in:
- Journal of Pathology, 2021, v. 255, n. 3, p. 285, doi. 10.1002/path.5769
- By:
- Publication type:
- Article
PD-L1 Expressing Recurrent Clear Cell Carcinoma of the Vulva with Durable Partial Response to Pembrolizumab: A Case Report.
- Published in:
- OncoTargets & Therapy, 2021, v. 14, p. 3921, doi. 10.2147/OTT.S309661
- By:
- Publication type:
- Article